<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Until recently the cannabinoid CB2 receptor was believed to be absent from the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="1" pm="."><plain>In this study we have identified CB2 expressing cells that appear in the rat brain following <z:hpo ids='HP_0001297'>stroke</z:hpo> and hypoxic-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>At 3 days following surgery CB2-positive macrophages, deriving from resident microglia and/or invading monocytes appear on the lesioned side of the brain </plain></SENT>
<SENT sid="3" pm="."><plain>By day 7, a mixed population of CB2-positive cells is present </plain></SENT>
<SENT sid="4" pm="."><plain>Microglia-derived macrophages are the key cells in the first stages of <z:mp ids='MP_0001847'>brain inflammation</z:mp>, and a pivotal step in the <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> that follows the <z:hpo ids='HP_0011009'>acute</z:hpo> stage of injury </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, CB2 may be important in the brain during injury, and in inflammatory <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The presence of CB2-positive cells in the brain following <z:hpo ids='HP_0001297'>stroke</z:hpo> may provide a novel strategy for cannabinoid-mediated intervention into <z:hpo ids='HP_0001297'>stroke</z:hpo> induced <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> without the psychoactive effects of CB1 receptor stimulation </plain></SENT>
</text></document>